Kartik Raghupathi

2.6k citations
22 papers · 2.0k indexed · 1 hit paper · h-index 9
Topics
Multiple Sclerosis Research Studies (9 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers)Lymphoma Diagnosis and Treatment (3 papers)

In The Last Decade

Kartik Raghupathi

20 papers receiving 1.9k citations

Hit Papers

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatira...201220262016202120122505007501000

Peers

Kartik Raghupathi
Comparison fields: 5 of 93
  • Pathology and Forensic Medicine 1.1k
  • Rheumatology 642
  • Immunology 484
  • Oncology 417
  • Molecular Biology 399
Replace Emmanuelle Le Page with:
Emmanuelle Le Page France
Ana de Vera Switzerland
Małgorzata Leyk United States
Jeffrey A. Cohen United States
Joachim Burman Sweden
Mark Novas United States
Jiameng Zhang United States
Juan C. Patarroyo United States
Violeta Rus United States
Alexander Korn Germany
Kartik Raghupathi relative to Emmanuelle Le Page France Emmanuelle Le Page's profile →
Citations per field
00.5×1.5×2.1×
Emmanuelle Le Page · 1×
Citations per year

Countries citing papers authored by Kartik Raghupathi

Since Specialization
Citations

This map shows the geographic impact of Kartik Raghupathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kartik Raghupathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kartik Raghupathi more than expected).

Fields of papers citing papers by Kartik Raghupathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kartik Raghupathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kartik Raghupathi. The network helps show where Kartik Raghupathi may publish in the future.

Co-authorship network of co-authors of Kartik Raghupathi

This figure shows the co-authorship network connecting the top 25 collaborators of Kartik Raghupathi. A scholar is included among the top collaborators of Kartik Raghupathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kartik Raghupathi. Kartik Raghupathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 26
3 1
4 197
5 205
6 0
7 12
8 3
9 2
10 6
11 1
12 1
13 1
14 34
15 0
16
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosisbreakdown →
1036
17 4
18 274
19
The Efficacy and Safety of Abatacept in SLE: Results of a 12-month Exploratory Study
15
20 117

About Kartik Raghupathi

Kartik Raghupathi is a scholar working on Pathology and Forensic Medicine, Rheumatology and Hepatology, having authored 22 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Rheumatology (642 citations) and Neurology (371 citations). Kartik Raghupathi has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include Eva Havrdová, Michael Hutchinson, Marianne T. Sweetser, Katherine Dawson, Mark Novas, J. Theodore Phillips, Vissia Viglietta, Robert J. Fox, David H. Miller and Mariko Kita. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026